Skip to main navigation Skip to search Skip to main content

In vitro and in vivo applications of alginate/iron oxide nanocomposites for theranostic molecular imaging in a brain tumor model

  • Chia Hao Su
  • , Fong Yu Cheng*
  • *Corresponding author for this work
  • Chang Gung Memorial Hospital
  • National Yang Ming Chiao Tung University
  • National Cheng Kung University

Research output: Contribution to journalJournal Article peer-review

18 Scopus citations

Abstract

Nanocomposites composed of highly biocompatible and safe alginate and iron oxide nanoparticles have been employed to encapsulate doxorubicine for brain tumor therapy. The antitumor activity of nanocomposites was demonstrated using in vitro and in vivo tests. The results significantly indicated that the nanocomposites had great safety and potential for brain tumor therapy.

Original languageEnglish
Pages (from-to)90061-90064
Number of pages4
JournalRSC Advances
Volume5
Issue number109
DOIs
StatePublished - 15 10 2015
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The Royal Society of Chemistry.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'In vitro and in vivo applications of alginate/iron oxide nanocomposites for theranostic molecular imaging in a brain tumor model'. Together they form a unique fingerprint.

Cite this